Secretory sphingomyelinase

Chemistry and Physics of Lipids

Volumn 102, Issue 1-2, 1999, Pages 123-130

  Tabas, Ira ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Atherogenesis; Ceramide; Endothelial cell; Lysosomes; Macrophages; Sphingomyelinase

Indexed keywords

CERAMIDE; PROTEIN PRECURSOR; SPHINGOMYELIN; SPHINGOMYELIN PHOSPHODIESTERASE;

ATHEROGENESIS; ENDOTHELIUM CELL; HUMAN; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; REVIEW; SIGNAL TRANSDUCTION;

EID: 0032868934     PISSN: 00093084     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-3084(99)00080-8     Document Type: Article

References (50)

1. Aloia R.C., Jensen F.C., Curtain C.C., Mobley P.W., Gordon L.M. Lipid composition and fluidity of the human immunodeficiency virus. Proc. Natl. Acad. Sci. USA. 85:1988;900-904.
2. Bao M., Booth J.L., Elmendorf B.J., Canfield W.M. Bovine UDP-Nacetylglucosamine:lysosomal-enzyme N-acetylglucosamine-1-phosphotransferase. I. Purification and subunit structure. J. Biol. Chem. 271:1996;31437-31445.
3. Bauer J., Sminia T., Wouterlood F.G., Dijkstra C.D. Phagocytic activity of macrophages and microglial cells during the course of acute and chronic relapsing experimental autoimmune encepalomyelitis. J. Neurosci. Res. 38:1994;365-375.
4. Brown M.S., Goldstein J.L. Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu. Rev. Biochem. 52:1983;223-261.
5. Callahan J.W., Jones C.S., Davidson D.J., Shankaran P. The active site of lysosomal sphingomyelinase: evidence for the involvement of hydrophobic and ionic groups. J. Neurosci. Res. 10:1983;151-163.
6. Cifone M.G., De Maria R., Roncaioli P., Rippo M.R., Azuma M., Lanier L.L., Santoni A., Testi R. Apoptotic signalling through CD95 (Fas/apo-1) activates an acidic sphingomyelinase. J. Exp. Med. 180:1994;1547-1552.
7. Cifone M.G., Roncaioli P., De Maria R., Camarda G., Santoni A., Ruberti G., Testi R. Multiple pathways originate at the Fas/APO-1 (CD95) receptor: sequential involvement of phosphatidylcholine-specific phospholipase C and acidic sphingomyelinase in the propagation of the apoptotic signal. EMBO J. 14:1995;5859-5868.
8. Donangelo C.M., Chang G.W. An enzymatic assay for available zinc in plasma and serum. Clin. Chim. Acta. 113:1981;201-206.
9. Galis Z.S., Sukhova G.K., Lark M.W., Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J. Clin. Invest. 94:1994;2493-2503.
10. Haimovitz-Friedman A., Cordon-Cardod C., Bayoumyb S., Garzottob M., McLoughlin M., Gallily R., Edwards C.K. III, Schuchman E.H., Fuks Z., Kolesnick R. Lipopolysaccharide induces disseminated endothelial apoptosis requiring ceramide generation. J. Exp. Med. 186:1997;1831-1841.
11. Harder T., Simons K. Caveolae, DIGs, and the dynamics of sphingolipidcholesterol microdomains. Curr. Opin. Cell Biol. 9:1997;534-542.
12. Hartung H.P., Jung S., Stoll G., Zielasek J., Schmidt B., Archelos J.J., Toyka K.V. Inflammatory mediators in demyelinating disorders of the CNS and PNS. J. Neuroimmunol. 40:1992;197-210.
13. He X., Miranda S.R.P., Dagan A., Gatt S., Schuchman E.H. Overexpression of human acid sphingomyelinase in Chinese hamster ovary cells. Purification and characterization of the recombinant enzyme. Biochem. Biophys. Acta. 1432:1998;251-264.
14. Hoff H.F., Morton R.E. Lipoproteins containing apo B extracted from human aortas: structure and function. Ann. N. Y. Acad. Sci. 454:1985;183-194.
15. Hurwitz R., Ferlinz K., Vielhaber G., Moczall H., Sandhoff K. Processing of human acid sphingomyelinase in normal and I-cell fibroblasts. J. Biol. Chem. 269:1994;5440-5445.
16. Jeong T.S., Schissel S.L., Tabas I., Pownall H.J., Tall A.R., Jiang X.C. Increased sphingomyelin content of plasma lipoproteins in apolipoprotein F, knockout mice reflects combined production and catabolic defects and enhances reactivity with mammalian sphingomyelinase. J. Clin. Invest. 101:1998;905-912.
17. Khoo J.C., Miller E., McLoughlin P., Steinberg D. Enhanced macrophage uptake of low density lipoprotein after self-aggregation. Arteriosclerosis. 8:1988;348-358.
18. Kornfeld S. Trafficking of lysosomal enzymes. FASEB J. 1:1987;462-468.
19. Lin X., Hengartner M.O., Kolesnick R. Caenorhabditis elegans contains two distinct acid sphingomyelinases. J. Biol. Chem. 273:1998;14374-14379.
20. Little C., Otnass A. The metal ion dependence of phospholipase C from Bacillus cereus. Biochim. Biophys. Acta. 391:1975;326-333.
21. Marathe S., Schissel S.L., Yellin M.J., Beatini N., Mintzer R., Williams K.J., Tabas I. Human vascular endothelial cells are a rich and regulatable source of secretory sphingomyelinase. Implications for early atherogenesis and ceramide-mediated cell signaling. J. Biol. Chem. 273:1998;4081-4088.
22. Maroudas A., Weinberg P.D., Parker K.H., Winlove C.P. The distributions and diffusivities of small ions in chondroitin sulphate, hyaluronate and some proteoglycan solutions. Biophys. Chem. 32:1988;257-270.
23. Menkin V. Studies on inflammation. X. The cytological picture of an inflammatory exudate in relation to its hydrogen ion concentration. Am. J. Pathol. 10:1934;193-210.
24. Merrill A.H., Jones D.D. An update of the enzymology and regulation of sphingomyelin metabolism. Biochim. Biophys. Acta. 1044:1990;1-12.
25. Milanino R., Moretti U., Concari E., Marrella M., Velo G.P. Copper and zinc status in adjuvant-arthritic rat: studies on blood, liver, kidneys, spleen and inflamed paws. Agents Actions. 24:1988;365-376.
26. Mohan Das D.V., Cook H.W., Spence M.W. Evidence that neutral sphingomyelinase of cultured murine neuroblastoma cells is oriented externally on the plasma membrane. Biochim. Biophys. Acta. 777:1984;339-342.
27. Mukherjee S., Ghosh R.N., Maxfield F.R. Endocytosis. Physiol. Rev. 77:1997;759-803.
28. Newrzella D., Stoffel W. Molecular cloning of the acid sphingomyelinase of the mouse and the organization and complete nucleotide sequence of the gene. Biol. Chem. Hoppe-Seyler. 373:1992;1233-1238.
29. Nievelstein P.F.E.M., Fogelman A.M., Mottino G., Frank J.S. Lipid accumulation in rabbit aortic intima 2 hours after bolus infusion of low density lipoprotein. Arterioscler. Thromb. 11:1991;1795-1805.
30. Palmiter R.D., Cole T.B., Findley S.D. ZnT-2, a mammalian protein that confers resistance to zinc by facilitating vesicular sequestration. EMBO J. 15:1996;1784-1791.
31. Pentikainen M.O., Lehtonen E.M.P., Kovanen P.T. Aggregation and fusion of modified low density lipoprotein. J. Lipid Res. 37:1996;2638-2649.
32. Ross R. Cell biology of atherosclerosis. Annu. Rev. Physiol. 57:1995;791-804.
33. Santana P., Pena L.A., Haimovitz-Friedman A., Martin S., Green D., McLoughlin M., Cordon-Cardo C., Schuchman E.H., Fuks Z., Kolesnick R. Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis. Cell. 86:1996;189-199.
34. Schissel S.L., Tweedie-Hardman J., Rapp J.H., Graham G., Williams K.J., Tabas I. Rabbit aorta and human atherosclerotic lesions hydrolyze the sphingomyelin of retained low-density lipoprotein. Proposed role for arterial-wall sphingomyelinase in subendothelial retention and aggregation of atherogenic lipoproteins. J. Clin. Invest. 98:1996;1455-1464.
35. 2+-stimulated sphingomyelinase is secreted by many cell types and is a product of the acid sphingomyelinase gene. J. Biol. Chem. 271:1996;18431-18436.
36. Schissel S.L., Keesler G.A., Schuchman E.H., Williams K.J., Tabas I. The cellular trafficking and zinc dependence of secretory and lysosomal sphingomyelinase, two products of the acid sphingomyelinase gene. J. Biol. Chem. 273:1998;18250-18259.
37. Schissel S.L., Jiang X.C., Tweedie-Hardman J., Jeong T.S., Camejo E.H., Najib J., Rapp J.H., Williams K.J., Tabas I. Secretory sphingomyelinase, a product of the acid sphingomyelinase gene, can hydrolyze atherogenic lipoproteins at neutral pH. Implications for atherosclerotic lesion development. J. Biol. Chem. 273:1998;2738-2746.
38. Silver I.A., Murrills R.J., Etherington D.J. Microelectrode studies on the acid microenvironment beneath adherent macrophages and osteoclasts. Exp. Cell Res. 175:1988;266-276.
39. Smith E.B. Metabolic activities in the arterial wall. Adv. Exp. Med. Biol. 115:1979;245-297.
40. Sorbi D., Fadly M., Hicks R., Alexander S., Arbeit L. Captopril inhibits the 72 kDa and 92 kDa matrix metalloproteinases. Kidney Int. 44:1993;1266-1272.
41. 2+-stimulated sphingomyelinase in fetal bovine serum. J. Biol. Chem. 264:1989;5358-5363.
42. Steinberg D., Parthasarathy S., Carew T.E., Khoo J.C., Witztum J.L. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320:1989;915-924.
43. Svensson M., Eriksson P., Persson J.K., Molander C., Arvidsson J., Aldskogius H. The response of central glia to peripheral nerve injury. Brain Res. Bull. 30:1993;499-506.
44. Tabas I. The stimulation of the cholesterol esterification pathway by atherogenic lipoproteins in macrophages. Curr. Opin. Lipidol. 6:1995;260-268.
45. Tapper H., Sundler R. Cytosolic pH regulation in mouse macrophages. Proton extrusion by plasma-membrane-localized H(+)-ATPase. Biochem. J. 281:1992;245-250.
46. Tomiuk S., Hofmann K., Nix M., Zumbansen M., Stoffel W. Cloned mammalian neutral sphingomyelinase: functions in sphingolipid signaling? Proc. Natl. Acad. Sci. USA. 95:1998;3638-3643.
47. van Genderen I.L., Brandimarti R., Torrisi M.R., Campadelli G., van Meer G. The phospholipid composition of extracellular herpes simplex virions differs from that of host cell nuclei. Virology. 200:1994;831-836.
48. Wiegmann K., Schutze S., Machleidt T., Witte D., Kronke M. Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling. Cell. 78:1994;1005-1015.
49. Williams K.J., Tabas I. The response-to-retention hypothesis of early atherogenesis. Arterioscler. Thromb. Vasc. Biol. 15:1995;551-561.
50. Xu X., Tabas I. Sphingomyelinase enhances low density lipoprotein uptake and ability to induce cholesteryl ester accumulation in macrophages. J. Biol. Chem. 266:1991;24849-24858.